Compare REKR & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | REKR | XTNT |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.7M | 39.6M |
| IPO Year | 2017 | 2009 |
| Metric | REKR | XTNT |
|---|---|---|
| Price | $0.19 | $0.21 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $0.75 |
| AVG Volume (30 Days) | ★ 2.6M | 226.9K |
| Earning Date | 11-12-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 4.35 | ★ 125.00 |
| EPS | N/A | ★ N/A |
| Revenue | $9,234,000.00 | ★ $53,337,000.00 |
| Revenue This Year | $5.38 | N/A |
| Revenue Next Year | $16.68 | $10.30 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.21 | $0.17 |
| 52 Week High | $1.96 | $0.84 |
| Indicator | REKR | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 29.96 | 27.58 |
| Support Level | N/A | N/A |
| Resistance Level | $0.48 | $0.47 |
| Average True Range (ATR) | 0.03 | 0.03 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 0.91 | 26.33 |
Rekor Systems Inc is a roadway intelligence company focused on modernizing public safety, urban mobility, and transportation management through solutions. The company delivers services and solutions that collect, connect, and organize mobility data, providing real-time insights to support decision making, enhance situational awareness, enable rapid response, and support predictive analytics. The Company derives its revenues mainly from the licensing and sale of its roadway data and traffic management product and service offerings. These offerings include a mixture of data collection, implementation, engineering, customer support, and maintenance services, as well as software and hardware. The company operates in the United States and other regions.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.